Working Together Across the Cardiomyopathy Care Pathway

A collaborative working group for organizations committed to improving diagnosis and care in cardiomyopathy.

Join the Collective

What We Are

The Cardiomyopathy Collective is a collaborative working group for organizations working across the cardiomyopathy landscape—biopharma, device, diagnostics, and beyond.

Participation is not contingent on funding or testing. Companies join because they share a common goal: improving diagnosis and care in cardiomyopathy, and learning from one another rather than working in silos.

Separately, some partners may choose to contribute to a pooled sponsored testing effort, which supports shared diagnostic initiatives rather than individual company programs. That participation is optional and does not define membership in the Collective.

"Every company in this space is trying to solve a piece of the same problem. We can either do that work in parallel—or we can do it together."

Why Now

Despite clear clinical guidelines, the diagnostic gap remains enormous.

~1%
of eligible cardiomyopathy patients receive genetic testing

Delayed Diagnosis

Patients wait too long to receive appropriate treatment and care.

Missed Precision Care

Genetic insights that could guide therapy are never obtained.

Families at Risk

Without cascade testing, relatives remain undiagnosed.

Limited Evidence

Real-world data gaps slow research and therapeutic development.

How It Works

Two distinct pathways, one shared mission.

Working Group Participation

Open to All
  • Shape priorities and agenda
  • Participate in collaborative projects
  • Shared learning across the field
  • Collective credibility
  • Co-development opportunities

Testing Contribution

Optional
  • Support pooled sponsored testing
  • Enable free testing for patients
  • Recognition as contributing partner
  • Shared insights from initiatives
  • Help shape testing-related questions

What We Work On Together

The agenda is shaped by members. Here are some possibilities:

Cardiomyopathy Lexicon

Shared language and definitions for subtypes, diagnostic criteria, and care pathways.

Diagnostic Pathway Mapping

Understanding how patients move through recognition, testing, and diagnosis—and where gaps exist.

Provider Education

Coordinated efforts to increase appropriate testing and guideline-based care.

Real-World Insights

Aggregate, de-identified data that benefits the entire field.

Get Involved

Participation is free during formation

We're forming the Cardiomyopathy Collective now and inviting organizations who share our commitment to improving cardiomyopathy care to join us.

Virtual Kickoff

Wednesday, March 12, 2025

12:00 PM – 1:00 PM ET

In-Person at ACC

Late March 2025

Informal meetup, details to follow

To RSVP or learn more, contact us:

Contact Us to Join